Skip to main content
NVDA+0.07%GOOGL+0.30%AAPL+0.08%MSFT-0.04%AMZN+0.08%TSM+0.45%AVGO+0.08%TSLA-0.12%META+0.30%MU+0.74%LLY+0.01%BRK-B-0.03%WMT-0.01%JPM-0.01%AMD+0.81%ASMLa+3.40%INTC+0.69%V-0.03%XOM0.00%JNJ0.00%0700.HK+1.40%ORCL+0.02%CSCO-0.02%LRCX0.00%AMAT-0.01%AP2d+5.34%COST+0.01%1398.HK+3.44%MA-0.03%CAT-0.01%ARM-0.08%ABBV-0.04%BAC-0.04%CVX-0.15%UNH-0.10%KO-0.02%GE-0.03%PG-0.02%NFLX+0.10%MS0.00%HD-0.03%1816.HK+3.07%0857.HK+1.37%HSBA.L+3.86%0005.HK+3.10%GS+0.01%3988.HK+2.98%MCp+3.53%NVS-0.02%PM+0.07%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURHKD0.00%AUDCAD0.00%EURUSD0.00%AUDDKK0.00%CADJPY0.00%USDZAR0.00%USDNOK0.00%CHFNOK0.00%GBPZAR0.00%USDSEK0.00%USDHKD0.00%EURCZK0.00%EURNZD0.00%EURSEK0.00%USDTRY0.00%NZDCHF0.00%NZDCAD0.00%AUDJPY0.00%EURPLN0.00%GBPSGD0.00%USDCNH0.00%USDPLN0.00%EURJPY0.00%USDTHB0.00%USDSGD0.00%NZDJPY0.00%EURNOK0.00%EURAUD0.00%PLNJPY0.00%CADCHF0.00%AUDCHF0.00%USDCHF0.00%GBPCAD0.00%EURCAD0.00%CHFSEK0.00%GBPCHF0.00%AUDNOK0.00%GBPAUD0.00%USDMXN0.00%NOKJPY0.00%NZDSGD0.00%EURSGD0.00%GBPJPY0.00%SGDJPY0.00%AUDNZD0.00%GBPUSD0.00%AUDSGD0.00%NZDUSD0.00%USDDKK0.00%NZDMXN0.00%EURCHF0.00%CHFJPY0.00%USDJPY0.00%EURZAR0.00%USDCAD0.00%EURGBP0.00%AUDUSD0.00%EURCNH0.00%EURDKK0.00%CHFSGD0.00%GBPNZD0.00%GAGUSD0.00%XAUUSD0.00%UKOIL0.00%GAUUSD0.00%USOIL0.00%W10.00%XAGUSD0.00%C10.00%XNGUSD0.00%S10.00%XPTUSD0.00%HG10.00%BTCUSDT-16.09%BTCUSD-0.07%ETHUSD+0.03%USDTUSD-0.01%BNBUSDT-3.98%XRPUSD+0.22%SOLUSD-0.26%TRXUSDT+0.05%DOGEUSD-0.01%ADAUSDT-33.13%ZECUSDT+0.25%XMRUSDT-0.26%XLMUSD+0.07%XLMUSDT+4.80%LINKUSD-0.01%TONUSD-0.89%AVAXUSDT-30.99%BCHUSDT-0.15%SUIUSDT-21.13%LTCUSD-0.15%HBARUSDT-0.34%TONUSDT+25.45%SUIUSD-0.11%TAOUSDT-0.61%UNIUSDT-23.67%NEARUSDT+52.75%UNIUSD-0.02%DOTUSDT+0.05%WLDUSDT-0.73%ICPUSDT-0.23%ETCUSDT-17.42%PEPEUSD+10290566.19%ONDOUSDT-0.02%AAVEUSD-0.33%ATOMUSDT-0.38%JUPUSDT-0.79%INJUSDT-3.20%FETUSDT-0.12%ARBUSDT-0.18%PENGUUSDT+99728.52%SEIUSDT+0.39%STXUSDT-0.27%TIAUSDT-0.70%IMXUSDT-0.64%PYTHUSDT-0.58%GRTUSDT-0.47%OPUSDT-0.54%IOTAUSDT-0.55%NVDA+0.07%GOOGL+0.30%AAPL+0.08%MSFT-0.04%AMZN+0.08%TSM+0.45%AVGO+0.08%TSLA-0.12%META+0.30%MU+0.74%LLY+0.01%BRK-B-0.03%WMT-0.01%JPM-0.01%AMD+0.81%ASMLa+3.40%INTC+0.69%V-0.03%XOM0.00%JNJ0.00%0700.HK+1.40%ORCL+0.02%CSCO-0.02%LRCX0.00%AMAT-0.01%AP2d+5.34%COST+0.01%1398.HK+3.44%MA-0.03%CAT-0.01%ARM-0.08%ABBV-0.04%BAC-0.04%CVX-0.15%UNH-0.10%KO-0.02%GE-0.03%PG-0.02%NFLX+0.10%MS0.00%HD-0.03%1816.HK+3.07%0857.HK+1.37%HSBA.L+3.86%0005.HK+3.10%GS+0.01%3988.HK+2.98%MCp+3.53%NVS-0.02%PM+0.07%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURHKD0.00%AUDCAD0.00%EURUSD0.00%AUDDKK0.00%CADJPY0.00%USDZAR0.00%USDNOK0.00%CHFNOK0.00%GBPZAR0.00%USDSEK0.00%USDHKD0.00%EURCZK0.00%EURNZD0.00%EURSEK0.00%USDTRY0.00%NZDCHF0.00%NZDCAD0.00%AUDJPY0.00%EURPLN0.00%GBPSGD0.00%USDCNH0.00%USDPLN0.00%EURJPY0.00%USDTHB0.00%USDSGD0.00%NZDJPY0.00%EURNOK0.00%EURAUD0.00%PLNJPY0.00%CADCHF0.00%AUDCHF0.00%USDCHF0.00%GBPCAD0.00%EURCAD0.00%CHFSEK0.00%GBPCHF0.00%AUDNOK0.00%GBPAUD0.00%USDMXN0.00%NOKJPY0.00%NZDSGD0.00%EURSGD0.00%GBPJPY0.00%SGDJPY0.00%AUDNZD0.00%GBPUSD0.00%AUDSGD0.00%NZDUSD0.00%USDDKK0.00%NZDMXN0.00%EURCHF0.00%CHFJPY0.00%USDJPY0.00%EURZAR0.00%USDCAD0.00%EURGBP0.00%AUDUSD0.00%EURCNH0.00%EURDKK0.00%CHFSGD0.00%GBPNZD0.00%GAGUSD0.00%XAUUSD0.00%UKOIL0.00%GAUUSD0.00%USOIL0.00%W10.00%XAGUSD0.00%C10.00%XNGUSD0.00%S10.00%XPTUSD0.00%HG10.00%BTCUSDT-16.09%BTCUSD-0.07%ETHUSD+0.03%USDTUSD-0.01%BNBUSDT-3.98%XRPUSD+0.22%SOLUSD-0.26%TRXUSDT+0.05%DOGEUSD-0.01%ADAUSDT-33.13%ZECUSDT+0.25%XMRUSDT-0.26%XLMUSD+0.07%XLMUSDT+4.80%LINKUSD-0.01%TONUSD-0.89%AVAXUSDT-30.99%BCHUSDT-0.15%SUIUSDT-21.13%LTCUSD-0.15%HBARUSDT-0.34%TONUSDT+25.45%SUIUSD-0.11%TAOUSDT-0.61%UNIUSDT-23.67%NEARUSDT+52.75%UNIUSD-0.02%DOTUSDT+0.05%WLDUSDT-0.73%ICPUSDT-0.23%ETCUSDT-17.42%PEPEUSD+10290566.19%ONDOUSDT-0.02%AAVEUSD-0.33%ATOMUSDT-0.38%JUPUSDT-0.79%INJUSDT-3.20%FETUSDT-0.12%ARBUSDT-0.18%PENGUUSDT+99728.52%SEIUSDT+0.39%STXUSDT-0.27%TIAUSDT-0.70%IMXUSDT-0.64%PYTHUSDT-0.58%GRTUSDT-0.47%OPUSDT-0.54%IOTAUSDT-0.55%

Nara Organics recalls infant formula

NEWS

June 14, 2026 at 07:13 UTC

3 min read
Powdered infant formula in a lab setting amid recall and safety probe of organic milk powder

Key Points

  • 01Nara Organics recalled all Whole Milk Organic Powdered Infant Formula on June 13, 2026
  • 02FDA urged the recall after recommending removal amid an investigation into potential links with a multistate infant botulism outbreak
  • 03CDC issued a food safety alert telling caregivers to stop using the product
  • 04Laboratory testing of multiple Nara Organics formula samples is underway

Nationwide recall of Nara Organics infant formula

On June 13, 2026, Nara Organics recalled all Nara Organics-brand Whole Milk Organic Powdered Infant Formula as part of an investigation into a multistate outbreak of infant botulism. The recall followed contact from the U.S. Food and Drug Administration on June 12, 2026, when the agency recommended that the company remove the product from the market. The action covers all Whole Milk Organic Infant Formula products sold under the Nara Organics brand.

Federal and state agencies, including the FDA, the Centers for Disease Control and Prevention, the California Department of Public Health, and the Infant Botulism Treatment and Prevention Program, are coordinating the investigation. The inquiry focuses on potential links between the formula and reported cases of infant botulism across multiple states.

Public health alert and consumer guidance

On June 13, 2026, the CDC issued a food safety alert advising parents and caregivers to immediately stop using any Nara Organics Whole Milk Organic Infant Formula. The alert applies to all such products regardless of lot number or purchase location. Caregivers are being directed to dispose of or return any unopened cans of the formula.

For opened cans, caregivers are instructed to take a photograph of the product and record the lot number and use-by date. The guidance recommends labeling opened cans with "DO NOT USE" and storing them separately for at least one month in case health authorities request them for testing. Clinicians who suspect infant botulism in a patient are advised to consult the Infant Botulism Treatment and Prevention Program for specialized guidance.

Laboratory testing and implicated lot codes

Federal and state officials have collected both opened and unopened Nara Organics product samples for laboratory testing. Analysis is underway to determine whether any of the tested products contain contamination associated with infant botulism. Authorities indicate that results from these laboratory tests are expected in the coming weeks.

Several recall notices and investigative reports identify three specific product lot codes as implicated in the outbreak investigation: 709125280E14F2, 709125288E14F2, and 708125174E14F2. While testing proceeds, regulators and the company are instructing consumers to stop using the product entirely, regardless of lot code, as a precautionary measure.

Ongoing investigation and next steps

Health authorities plan to update the public as laboratory results become available and the investigation progresses. The current focus is on determining the source and scope of the contamination risk and identifying any additional control measures that may be needed. The recall and alert will remain in effect while regulators review testing outcomes and epidemiological information.

Parents and caregivers are urged to follow the disposal and documentation instructions for any Nara Organics Whole Milk Organic Infant Formula they possess. The coordinated response among federal and state agencies is intended to limit further exposure while clarifying the connection between the formula and the multistate infant botulism cases.

Key Takeaways

  • 01All Nara Organics Whole Milk Organic Powdered Infant Formula products are under recall while a multistate infant botulism outbreak is investigated.
  • 02Regulators responded quickly, recommending a recall and issuing a safety alert within a short time frame as case information emerged.
  • 03Consumer actions—stopping use, discarding or returning cans, and preserving data on opened containers—are central to the public health response.
  • 04Laboratory results expected in the coming weeks will be critical to confirming contamination and guiding any further regulatory or clinical steps.